• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Mid-Day Market Update: Nasdaq Dips 300 Points; Apria Shares Surge

    1/10/22 12:26:23 PM ET
    $ALE
    $APR
    $AZZ
    $CTRN
    Power Generation
    Utilities
    Medical/Dental Instruments
    Health Care
    Get the next $ALE alert in real time by email

    Midway through trading Monday, the Dow traded down 1.23% to 35,787.07 while the NASDAQ fell 2.07% to 14,627.21. The S&P also fell, dropping, 1.52% to 4,605.95.

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 61,263,030 cases with around 859,350 deaths. India confirmed a total of at least 35,708,440 cases and 483,930 deaths, while Brazil reported over 22,523,900 COVID-19 cases with 620,030 deaths. In total, there were at least 308,004,270 cases of COVID-19 worldwide with more than 5,507,340 deaths.


    Leading and Lagging Sectors


    Utilities shares fell by just 0.3% on Monday. Meanwhile, top gainers in the sector included Xcel Energy Inc. (NASDAQ:XEL), up 1.4% and ALLETE, Inc. (NYSE:ALE) up 1.1%.


    In trading on Monday, consumer discretionary shares dipped by 2.9%.


    Top Headline


    AZZ Inc (NYSE:AZZ) reported upbeat earnings for its third quarter on Monday.

    AZZ posted quarterly earnings of $0.85 per share, beating analysts’ estimates of $0.82 per share. The company’s quarterly sales came in at $231.74 million, versus expectations of $238.63 million.

    AZZ reaffirmed FY22 sales guidance of $865 million to $925 million. The company said it sees FY22 EPS of $3.00 to $3.20.

     

    Equities Trading UP


    Molecular Partners AG (NASDAQ:MOLN) shares shot up 21% to $19.98 after the company, and Novartis, reported topline data from the Phase 2 study for ensovibep, a DARPin antiviral therapeutic for COVID-19.


    Shares of Zynga Inc. (NASDAQ:ZNGA) got a boost, shooting 45% to $8.69 after the company announced it will be acquired by Take-Two Interactive Software in a cash and stock transaction valued at $9.86 per Zynga share, representing a total enterprise value of approximately $12.7 billion.


    Apria, Inc. (NASDAQ:APR) shares were also up, gaining 26% to $37.40. Owens & Minor agreed to acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion.


    Check out these big movers of the day


    Equities Trading DOWN

    Citi Trends, Inc. (NASDAQ:CTRN) shares tumbled 16% to $68.00. Citi Trends reported 2021 holiday sales results and updated long-term strategic plan.


    Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) were down 22% to $8.91 after the company issued its preliminary and unaudited 2021 revenue, and full-year 2022 outlook and revenue guidance. Amicus Therapeutics said it sees FY21 Galafold sales of $306 million.


    Rapid Micro Biosystems, Inc. (NASDAQ:RPID) was down, falling 25% to $6.81. Rapid Micro Biosystems said it expects Q4 total revenue of between $4.7 and $5.2 million.


    Commodities

    In commodity news, oil traded down 0.3% to $78.64, while gold traded down 0.3% to $1,792.50.


    Silver traded down 0.1% Monday to $22.385 while copper fell 1.5% to $4.3455.


    Euro zone

    European shares were lower today. The eurozone’s STOXX 600 dropped 1.68%, London’s FTSE 100 fell 0.79%, while Spain’s IBEX 35 Index fell 0.75%. The German DAX dropped 1.34%, French CAC 40 declined 1.53% and Italy’s FTSE MIB Index dropped 1.19%.

    The unemployment rate in Italy dropped to 9.2% in November from 9.4% in the prior month.


    Economics


    US wholesale inventories rose 1.3% for November, versus analysts’ expectations for a 1.2% increase.

    Check out the full economic calendar here

    Get the next $ALE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALE
    $APR
    $AZZ
    $CTRN

    CompanyDatePrice TargetRatingAnalyst
    Amicus Therapeutics Inc.
    $FOLD
    1/22/2026$14.50Buy → Hold
    Jefferies
    Amicus Therapeutics Inc.
    $FOLD
    12/29/2025$14.50Outperform → Market Perform
    Leerink Partners
    Amicus Therapeutics Inc.
    $FOLD
    12/22/2025$14.50Buy → Hold
    TD Cowen
    Amicus Therapeutics Inc.
    $FOLD
    12/17/2025$17.00Buy
    Citigroup
    Xcel Energy Inc.
    $XEL
    10/28/2025$7.00Outperform
    RBC Capital Mkts
    Xcel Energy Inc.
    $XEL
    10/22/2025$96.00Buy
    BTIG Research
    Xcel Energy Inc.
    $XEL
    10/16/2025$93.00Buy
    TD Cowen
    Xcel Energy Inc.
    $XEL
    10/7/2025$92.00Outperform
    Evercore ISI
    More analyst ratings

    $ALE
    $APR
    $AZZ
    $CTRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Amicus Therapeutics downgraded by Jefferies with a new price target

    Jefferies downgraded Amicus Therapeutics from Buy to Hold and set a new price target of $14.50

    1/22/26 8:24:52 AM ET
    $FOLD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amicus Therapeutics downgraded by Leerink Partners with a new price target

    Leerink Partners downgraded Amicus Therapeutics from Outperform to Market Perform and set a new price target of $14.50

    12/29/25 7:10:03 AM ET
    $FOLD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amicus Therapeutics downgraded by TD Cowen with a new price target

    TD Cowen downgraded Amicus Therapeutics from Buy to Hold and set a new price target of $14.50

    12/22/25 8:32:24 AM ET
    $FOLD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALE
    $APR
    $AZZ
    $CTRN
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Amicus Therapeutics Inc.

    SCHEDULE 13G/A - AMICUS THERAPEUTICS, INC. (0001178879) (Subject)

    2/10/26 11:23:20 AM ET
    $FOLD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Rapid Micro Biosystems Inc.

    144 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Subject)

    2/9/26 4:33:38 PM ET
    $RPID
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    AZZ Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - AZZ INC (0000008947) (Filer)

    2/3/26 4:34:28 PM ET
    $AZZ
    Industrial Specialties
    Industrials

    $ALE
    $APR
    $AZZ
    $CTRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Mackey Tara D sold $397,528 worth of shares (2,923 units at $136.00), decreasing direct ownership by 12% to 22,373 units (SEC Form 4)

    4 - AZZ INC (0000008947) (Issuer)

    2/12/26 4:22:29 PM ET
    $AZZ
    Industrial Specialties
    Industrials

    CHIEF OPERATING OFFICER Wilson John J. Addington sold $17,438 worth of shares (4,610 units at $3.78), decreasing direct ownership by 2% to 257,768 units (SEC Form 4)

    4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)

    2/10/26 6:58:23 PM ET
    $RPID
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    CHIEF FINANCIAL OFFICER Wirtjes Sean M sold $22,798 worth of shares (6,027 units at $3.78), decreasing direct ownership by 1% to 483,928 units (SEC Form 4)

    4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)

    2/10/26 6:54:52 PM ET
    $RPID
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ALE
    $APR
    $AZZ
    $CTRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    LEXINGTON, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grants on February 2, 2026, of an aggregate of 205,000 restricted stock units ("RSUs") of the Company's Class A common stock ("Common Stock") and non-qualified stock options to purchase an aggregate of 168,000 shares of Common Stock (the "Options"), all as a material inducement to employment for three new employees. All such equity awards were made under the Company's Inducement

    2/12/26 4:15:00 PM ET
    $RPID
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Xcel Energy 2025 Year End Earnings Report

    2025 GAAP diluted earnings per share were $3.42 compared with $3.44 per share in 2024. 2025 diluted ongoing earnings per share were $3.80 compared with $3.50 per share in 2024. Xcel Energy reaffirms 2026 EPS guidance of $4.04 to $4.16 per share. Xcel Energy Inc. (NASDAQ:XEL) today reported 2025 GAAP diluted earnings of $2.02 billion, or $3.42 per share, compared with $1.94 billion, or $3.44 per share in the same period in 2024 and ongoing earnings of $2.24 billion, or $3.80 per share, compared with $1.97 billion, or $3.50 per share in the same period in 2024. See Note 6 for reconciliation from GAAP to ongoing earnings. The change in ongoing earnings reflect increased recovery of

    2/5/26 6:05:00 AM ET
    $XEL
    Power Generation
    Utilities

    AZZ Inc. Issues Fiscal Year 2027 Guidance

    FORT WORTH, Texas, Feb. 4, 2026 /PRNewswire/ -- AZZ Inc. (NYSE:AZZ), the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced financial guidance for fiscal year 2027. Fiscal year 2027 refers to the 12-month period beginning on March 1, 2026, and ending on February 28, 2027. FY2026 Guidance FY2027 Guidance (1) Sales $1.625 - $1.725 billion $1.725 - $1.775 billion Adjusted EBITDA $360 - $380 million $360 - $400 million Adjusted Diluted EPS $5.90 - $6.20 $6.50 - $7.00 (1) FY2027 Guidance Assumptions: a. The newly built Washington, Missou

    2/4/26 4:15:00 PM ET
    $AZZ
    Industrial Specialties
    Industrials

    $ALE
    $APR
    $AZZ
    $CTRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Stockfish Devin W bought $149,578 worth of shares (2,170 units at $68.93), increasing direct ownership by 259% to 3,007 units (SEC Form 4)

    4 - XCEL ENERGY INC (0000072903) (Issuer)

    3/12/25 4:07:01 PM ET
    $XEL
    Power Generation
    Utilities

    Director Pei Melinda Litherland bought $20,364 worth of shares (20,000 units at $1.02), increasing direct ownership by 58% to 54,300 units (SEC Form 4)

    4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)

    12/5/24 6:44:47 PM ET
    $RPID
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Pei Melinda Litherland bought $20,999 worth of shares (20,000 units at $1.05), increasing direct ownership by 140% to 34,300 units (SEC Form 4)

    4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)

    11/27/24 9:42:03 PM ET
    $RPID
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ALE
    $APR
    $AZZ
    $CTRN
    Leadership Updates

    Live Leadership Updates

    View All

    Xcel Energy Elects Maria Demaree to Board of Directors

    Demaree is a longtime technology, innovation leader from Lockheed Martin Xcel Energy Inc. (NASDAQ:XEL) announced today that Maria Demaree has been elected to its board of directors, effective December 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251217579124/en/Maria Demaree Demaree has been with Lockheed Martin for more than three decades, most recently serving as senior vice president, Enterprise Business and Digital Transformation, and chief information officer. She leads the defense technology company's enterprise IT strategy, including its 1LMX transformation program, encompassing digital enablement, IT delivery

    12/17/25 4:05:00 PM ET
    $XEL
    Power Generation
    Utilities

    Corebridge Financial Set to Join S&P MidCap 400

    NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Corebridge Financial Inc. (NYSE:CRBG) will replace Allete Inc. (NYSE:ALE) in the S&P MidCap 400 effective prior to the open of trading on Wednesday, December 17. Canada Pension Plan Investment Board and Global Infrastructure Partners are acquiring Allete in a deal expected to close soon, pending final closing conditions. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 17, 2025 S&P MidCap 400 Addition Corebridge Financial CRBG Financials Dec 17, 2025 S&P MidCap 400 Deletion Allete ALE Utilities ABOUT S&P DOW JONES INDICES S

    12/12/25 5:51:00 PM ET
    $ALE
    $CRBG
    $SPGI
    Power Generation
    Utilities
    Life Insurance
    Finance

    Astro Shapes Announces Appointment of Carol Jackson as Chief Executive Officer

    Astro Shapes, a leading manufacturer of custom aluminum extrusions, and a portfolio company of Wynnchurch Capital, L.P. ("Wynnchurch"), today announced the appointment of Carol Jackson as Chief Executive Officer. Ms. Jackson brings extensive executive experience and a proven track record of driving growth and operational excellence. She previously served as President, Chairman, and CEO of HarbisonWalker International (HWI), now part of Calderys. Prior to joining HWI in 2014, she was Vice President of the bar, wire, and strip business units at Carpenter Technology Corporation (NYSE:CRS). Earlier in her career, she spent over 12 years at PPG Industries (NYSE:PPG), where she held numerous lea

    12/2/25 10:05:00 AM ET
    $AZZ
    $CRS
    $PPG
    Industrial Specialties
    Industrials
    Steel/Iron Ore
    Paints/Coatings

    $ALE
    $APR
    $AZZ
    $CTRN
    Financials

    Live finance-specific insights

    View All

    Xcel Energy 2025 Year End Earnings Report

    2025 GAAP diluted earnings per share were $3.42 compared with $3.44 per share in 2024. 2025 diluted ongoing earnings per share were $3.80 compared with $3.50 per share in 2024. Xcel Energy reaffirms 2026 EPS guidance of $4.04 to $4.16 per share. Xcel Energy Inc. (NASDAQ:XEL) today reported 2025 GAAP diluted earnings of $2.02 billion, or $3.42 per share, compared with $1.94 billion, or $3.44 per share in the same period in 2024 and ongoing earnings of $2.24 billion, or $3.80 per share, compared with $1.97 billion, or $3.50 per share in the same period in 2024. See Note 6 for reconciliation from GAAP to ongoing earnings. The change in ongoing earnings reflect increased recovery of

    2/5/26 6:05:00 AM ET
    $XEL
    Power Generation
    Utilities

    AZZ Inc. Issues Fiscal Year 2027 Guidance

    FORT WORTH, Texas, Feb. 4, 2026 /PRNewswire/ -- AZZ Inc. (NYSE:AZZ), the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced financial guidance for fiscal year 2027. Fiscal year 2027 refers to the 12-month period beginning on March 1, 2026, and ending on February 28, 2027. FY2026 Guidance FY2027 Guidance (1) Sales $1.625 - $1.725 billion $1.725 - $1.775 billion Adjusted EBITDA $360 - $380 million $360 - $400 million Adjusted Diluted EPS $5.90 - $6.20 $6.50 - $7.00 (1) FY2027 Guidance Assumptions: a. The newly built Washington, Missou

    2/4/26 4:15:00 PM ET
    $AZZ
    Industrial Specialties
    Industrials

    Xcel Energy 2025 Year End Earnings Conference Call

    On Thursday, February 5, 2026, Xcel Energy (NASDAQ:XEL) will host a conference call to review fourth quarter and year end 2025 financial results. The earnings report will be released prior to the market open on the same date. The call will begin at 9:00 a.m. Central Time. To participate in the conference call, please dial in at least 10 minutes prior to the scheduled start and follow the operator's instructions. U.S. Toll-Free Dial-In: 1-800-715-9871 U.S. / International Toll Dial-In: 1-646-307-1963 Conference ID: 5265704 The conference call will be simultaneously webcast and archived on our website at the following location: www.xcelenergy.com Under Company, select: Investors Th

    1/16/26 5:31:00 PM ET
    $XEL
    Power Generation
    Utilities

    $ALE
    $APR
    $AZZ
    $CTRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Citi Trends Inc.

    SC 13G/A - Citi Trends Inc (0001318484) (Subject)

    12/6/24 4:29:10 PM ET
    $CTRN
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Citi Trends Inc.

    SC 13G/A - Citi Trends Inc (0001318484) (Subject)

    12/6/24 4:22:55 PM ET
    $CTRN
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Amicus Therapeutics Inc.

    SC 13G/A - AMICUS THERAPEUTICS, INC. (0001178879) (Subject)

    11/14/24 9:00:58 PM ET
    $FOLD
    Biotechnology: Pharmaceutical Preparations
    Health Care